GT Biopharma, Inc.
GTBP· Nasdaq
GTBPGT Biopharma, Inc.
Filed Aug 22, 2011 · 10-Q · 53 days after period end · 0001513160-11-000053
| Metric | Q2 2011 | Q2 2010 |
|---|---|---|
| Revenue | $1.00K | $0.00 |
| Net Income | -$662.00K | $399.00K |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
GT Biopharma, Inc. · CIK 109657 · Engraved from SEC EDGAR
ended Jun 30, 2011 · filed Aug 22, 2011 · 53 d after period end
